Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Isis Pharmaceuticals, Inc.
ISIS Pharmaceuticals shares reached a 4-month high Tuesday gaining over 11 percent on nearly four-times the average daily volume Wednesday. On Wednesday, the U.S. Food and Drug Administration approved the company’s new drug application for Kynamro, a treatment for a rare form of high cholesterol.
Going forward ... (see research report)
Subscribe to News Feeds